Active in the pharmaceutical market, with emphasis on the
development of unique products based on selective receptor
activation.
Employees: 18
Overview
SE-CURE PHARMACEUTICALS & COSMETICS LTD. is active in the
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
pharmaceutical market, with emphasis on the development of unique
products based on selective receptor activation.
SE-CURE developed unique technology focusing the treatment on
target tissues, activating or blocking receptors that have an
impact on the pathology.
SE-CURE develops and manufactures pharmacological solutions in
the fields of:
* Endocrinology- "Femarelle" - A combined treatment for menopause
and osteoporosis prevention. Stage - Marketing & Sales.
* Urology- Prostate treatment- Reducing the prostate to its
original size, preventing urinary incontinence. Stage -R&D for
conceptualization of final product.
* Dermatology- Emergency IV treatment for the prevention of
formation of Stasis in severe burns. Stage - Conceptual stage in
R&D following pre-clinical study on guinea pigs, which showed
outstanding results.
SE-CURE PHARMACEUTICALS & COSMETICS LTD. was founded following a
major research breakthrough and focuses on the development of
ethical medicines. The development effort is carried out by
research teams in various scientific fields whose expertise is
identifying substances that generate selective physiological
responses.
As a result of the exceptional breakthrough and following its
development into a unique end product, in 1999 SE-CURE began to
market its first product internationally. This product, marketed
under the names Tofupill and Femarelle, focuses on the
integrative treatment of menopause and osteoporosis. The product
has been tested in numerous trials published in leading
scientific journals worldwide that prove its effectiveness and
safety of use. The research process continues and new studies are
constantly being planned in order to provide the best scientific
coverage for the product.
Following the success of SE-CURE's first product, the R&D team
was expanded and additional products in the areas of dermatology
and gynecology are currently in advanced stages of development.
SE-CURE utilizes modern manufacturing facilities for the
production of the raw materials as well as of capsules and
tablets, and for the packaging of the final product.
The policy of SE-CURE's R&D, that all products developed will not
involve any synthesizing or other chemical processes, has brought
the company to find unique technological solutions for safe
isolation procedures of the active matter through the use of
other natural materials. This uniqueness differentiates SE-CURE's
biotechnological products from all the synthetic and extracted
products found in the market today. This principle enables the
creation of products that offer safe modern solutions based on
the accumulated knowledge of natural medicine that have the
advantage of thousands of years of practice to the benefits and
drawbacks of all materials.
